Clusterin in disease pathology
Clusterin in disease pathology is a research topic within Oncology. Science Explorer counts 4.8k research works in it since 1954. 19.2% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the multifaceted role of Clusterin, a chaperone protein, in cancer development, progression, and therapy. It investigates its involvement in apoptosis inhibition, TGF-ß signaling modulation, angiogenesis promotion, chemoresistance, and its potential as a biomarker for various cancers. The papers also discuss the implications of Clusterin in metastasis, particularly in prostate cancer.
- Clusterin
- Chaperone
- Apoptosis
- Cancer
- Metastasis
- TGF-ß Signaling
- Angiogenesis
- Prostate Cancer
- Chemoresistance
- Biomarker
- Research works
- 4.8k fractional, since 1954
- In the world top 10%
- 914 per year above
- Top-10% rate
- 19.2% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +22% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Clusterin in disease pathology research?
By volume, China and the United States publish the most (589 and 129 works in 2022–2025).
By volume, 2022–2025
- 1 China 589 works
- 2 United States 129 works
- 3 Japan 54 works
- 4 India 25 works
- 5 United Kingdom 25 works
- 6 Germany 23 works
- 7 Türkiye 20 works
- 8 South Korea 19 works
- 9 Egypt 18 works
- 10 Iran 17 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Clusterin in disease pathology research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Clusterin in disease pathology research, followed by Sun Yat-sen University and Central South University.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical College China 8 works
- 2 Sun Yat-sen University China 8 works
- 3 Central South University China 8 works
- 4 Nanjing Medical University China 8 works
- 5 Shanghai Jiao Tong University China 5 works
- 6 Harbin Medical University China 5 works
- 7 Fujian Medical University China 5 works
- 8 Nanjing University of Chinese Medicine China 5 works
- 9 Shanghai University of Traditional Chinese Medicine China 5 works
- 10 Wuhan University China 5 works
Who are the leading researchers in Clusterin in disease pathology?
The most-cited researchers publishing on Clusterin in disease pathology include Dirk Schadendorf, Georgina V. Long and Fred Saad.
- 1 Dirk Schadendorf 4.4k citations
- 2 Georgina V. Long 2.8k citations
- 3 Fred Saad 2.7k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Clusterin in disease pathology research done?
The largest centres of Clusterin in disease pathology research in 2022–2025 are Shanghai (China), Beijing (China), Guangzhou (China) and Changsha (China). Among places with at least 20 works in it, it is an unusually large share of all research in Changsha and Guangzhou.
Largest cities, 2022–2025
Where it is the local speciality
- ChangshaCN · 26.2 works4.9×
- GuangzhouCN · 40.1 works4.2×
Location quotient: how much more of its research is in Clusterin in disease pathology than the world average.
Where is the best place to study Clusterin in disease pathology?
Among universities, judged by research, Chinese Academy of Medical Sciences & Peking Union Medical College score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Chinese Academy of Medical Sciences & Peking Union Medical College China | 0.0 | 21.1% | 7.9× | 8 | -9.2% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Clusterin in disease pathology research growing?
Output in 2018–2022 was 22% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Clusterin in disease pathology.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.